ABC | Volume 113, Nº2, Agosto 2019

Artigo Original Kul et al OPS e diabetes tipo 2 Arq Bras Cardiol. 2019; 113(2):207-215 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 17. Korkmaz L, Akyüz AR, Gurbak I, ErkanH, Dursun I, Celik S, et al. Presystolic Awavemay predict increased arterial stiffness in asymptomatic individuals. Blood Press Monit. 2016; 21(3):144-8. 18. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group; American Society of Echocardiography’’s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–63. 19. Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, GalderisiM,etal.Recommendationsontheuseofechocardiography inadult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015;16(6):577–605. 20. Akyüz AR, Korkmaz L, Turan T, Kırış A, Erkan H, Ağaç MT, et al. Assessment of right ventricular function by isovolumic contraction acceleration before and after percutaneous closure of atrial septal defects: a preliminary study. Anadolu Kardiyol Derg. 2014;14(5):417-21. 21. AğaçMT, Akyüz AR, Acar Z, Akdemir R, Korkmaz L, Kırış A, et al. Evaluation of right ventricular function in early period following transcatheter closure of atrial septal defect. Echocardiography. 2012;29(3):358–62. 22. Joshi KR, Kabirdas D, Romero-Corral A, Shah M, Figueredo VM, Pressman GS. Clinical significance of a presystolic wave on Doppler examination of the left ventricular outflow tract. Am J Cardiol. 2014;114(10):1599-602. 23. Akyüz AR, Turan T, Gürbak İ, Korkmaz L, Ağaç MT, Çelik Ş. The relationship between presystolic wave and subclinical left ventricular dysfunction in asymptomatic hypertensive patients. Blood Press Monit. 2016;21(5):277-81. 24. American Diabetes Association. [Cited in 25 Dec 2013] Diabetes statistics. 2011. Available from [www.diabetes.org/diabetes-basics/ diabetes-statistics/] 25. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595–602. 26. de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens. 2010;28(2):353–60. 27. Litwin SE. Diabetes and the heart: is there objective evidence of a human diabetic cardiomyopathy? Diabetes. 2013;62(10):3329–30. 28. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597–605. 29. Norton GR, Candy G, Woodiwiss AJ. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation. 1996; 93(10):1905–12. 30. Singh R, Barden A, Mori T, Beilin L. Advanced glycation endproducts: a review. Diabetologia. 2001;44(2):129-46. 31. StahrenbergR,EdelmannF,MendeM,KockskämperA,DüngenHD,Scherer M, et al. Association of glucosemetabolismwith diastolic function along the diabetic continuum. Diabetologia. 2010;53(7):1331-40. 32. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemiainduced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002;51(6):1938-48. 33. Bojunga J, Nowak D, Mitrou PS, Hoelzer D, Zeuzem S, Chow KU. Antioxidative treatment prevents activation of death-receptorand mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia. 2004;47(12):2072-80. 34. Harada K, Tamura M, Toyono M, Oyama K, Takada G. Assessment of global left ventricular function by tissue Doppler imaging. Am J Cardiol. 2001;88(8):927–32, A9. 35. Adar A, Kırış A, Bülbül Y, Bektaş H, Acat M, Casim H, et al. Association of fragmentedQRSwith subclinical left ventricular dysfunction in patients with obstructive sleep apnea. Med Princ Pract. 2015;24(4):376–81. 36. Karatzis EN, Giannakopoulou AT, Papadakis JE, Karazachos AV, Nearchou NS. Myocardial performance index (Tei index): evaluating its application to myocardial infarction. Hellenic J Cardiol. 2009;50(1):60–5. 37. Tei C, Ling LH, HodgeDO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26(6):357–66. 215